Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

908 Devices Inc. - Common Stock (NQ: MASS )

2.010 +0.090 (+4.69%)
Streaming Delayed Price Updated: 2:33 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about 908 Devices Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
MASS Stock Earnings: 908 Devices Misses EPS, Beats Revenue for Q2 2024
MASS stock results show that 908 Devices missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Via Benzinga
$2.8M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024
MASS stock results show that 908 Devices beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
908 Devices Earnings Preview
Via Benzinga
Earnings Preview: 908 Devices
Via Benzinga
Earnings Outlook For 908 Devices
Via Benzinga
908 Devices Is Well Positioned, Analyst Says While Initiating Coverage
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
On Thursday, Cathie Wood-led Ark Invest made some significant trades, with Coinbase Global Inc (NASDAQ:COIN) and Palantir Technologies Inc (NYSE:PLTR) being the most prominent. 
Via Benzinga
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street
Wall Street is uber-bullish on these two Ark Invest holdings. 
Via The Motley Fool
3 Russell 2000 Stocks That Are About to Get Absolutely Crushed
The Russell 2000 has only begun closing its wide gap with other indices, but investors should be weary of these three stocks to sell. 
Via InvestorPlace
Looking Into 908 Devices's Return On Capital Employed
Via Benzinga
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
12 Information Technology Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Monday's After-Market Session
Via Benzinga
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street
These cutting-edge biotech stocks could deliver life-changing gains for early shareholders. 
Via The Motley Fool
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
12 Information Technology Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 34 companies set new 52-week lows. 
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.